Tucked inside Trump's drug-pricing executive order is an apparent threat to withdraw drugmakers' medicines if they do not lower prices

AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity. Here’s how to do it.

The package revives President Donald Trump’s much-maligned Most Favored Nation rule but goes further into the private markets and beyond, leveraging the patent system, drug importation and more.

Tucked inside President Trump's executive order on drug pricing is a sentence that appears to threaten the FDA could yank approvals if drugmakers do not lower prices.

"These trends won't start on their own." Experts raise red flag after researching pharmaceutical industry: 'We need government intervention' first appeared on The Cool Down.

RFK Jr. told Americans President Trump cannot be bought while also revealing Trump accepted $100 million from Big Pharma.

Antibiotics, antidepressants and other drugs frequently leach into the environment, where they can impact ecosystems and human health.

The company then offers to sell or analyze that de-identified information for its clients in the pharmaceutical industry. In the other model, the clinic is a subsidiary of the company collecting ...

The pharmaceutical industry, which is well known for its well-resourced lobbying campaigns, has a lesser-known tactic for influencing policy: bankrolling ostensibly independent nonprofit organizations to push industry talking points in Washington and across the nation.